Document is current
Any future updates will be listed below
-
Authors
Wuyts, Wim A.
Bonella, Francesco
Scarpa, Maurizio
Kapetanakis, Venediktos
Shukla, Pragya
Fournier, Marie
Gasparic, Maja
Pulikottil-Jacob, Ruth
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 24 September 2025
Accepted: 17 December 2025
First Online: 16 February 2026
Declarations
:
: Wim A. Wuyts received funds for advisory boards from Sanofi, Boehringer Ingelheim, Alentis, and Roche. Francesco Bonella received speaker and advisor honoraria, and travel cost refunds from Sanofi, Boehringer Ingelheim and Savara Pharma. Maurizio Scarpa received research funding and honoraria from Sanofi, Takeda, Chiesi, Ultragenyx, Amicus, Azafaros, BioMarin, and Orchard. Venediktos Kapetanakis and Pragya Shukla are employees of Evidera, a part of Thermo Fisher Scientific, which received fees from Sanofi for the conduct of statistical analyses. Maja Gasparic and Marie Fournier are employees of Sanofi and may hold stocks and/or stock options in the company. Ruth Pulikottil-Jacob was an employee of Sanofi at the time of study conduct and may hold stocks and/or stock options in the company.
: This article is a post hoc analysis on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
